Results 61 to 70 of about 1,026 (172)
Genotypes of Hepatitis B and D Viruses Among Patients With Hepatitis D in the United States
Journal of Viral Hepatitis, Volume 33, Issue 7, July 2026.ABSTRACT
The epidemiological landscape of paired hepatitis B virus (HBV)/hepatitis delta virus (HDV) genotype (GT) among patients with HDV in the US remains unknown. HBV/HDV genotypes were assessed in two independent US cohorts: Cohort 1 included 5222 HBV‐positive patients from Quest Diagnostics, including 114 anti‐HDV+ patients; Cohort 2 included 178 ...Andrew Lopez, Harish Gopalakrishna, Silvia Chang, Savrina Manhas, Nadine Peinovich, Christopher Richards, Grace Chee, Ross Martin, Roberto Mateo, Maria Mironova, Brooke E. Swanson, William A. Meyer III, Elizabeth M. Marlowe, Chunfeng Li, Hongmei Mo, Theo Heller, Evguenia Maiorova, Christopher Koh +17 morewiley +1 more sourceLong-Term
Strategies for Poorly Water-Soluble Peptides:
Combining Fatty Acid Modification with PAS Fusion
, 2023 Bulevirtide, an entry inhibitor for the hepatitis B virus
(HBV)
and hepatitis D virus (HDV), is currently available on the European
market. However, its clinical application is constrained by its short
half-life and poor water solubility, rendering it ...Haoju Hua (17535590), Qin Lu (995), Yanzhen Dong (17535593), Jinhua Zhang (326358), Jun Feng (116162), Hongjiang Xu (2831921), Hongxiang Zhu (7401260), Xingfeng Ge (17535596) +7 morecore +1 more sourceLiver Transplantation for HBV‐Related Disease in France: NUC Type Before LT Is Associated With Patient Survival
Liver International, Volume 46, Issue 7, July 2026.ABSTRACT Background & Aims
Liver transplantation (LT) is indicated for liver complications related to hepatitis B virus (HBV) infection: acute liver failure (ALF), decompensated cirrhosis or hepatocellular carcinoma (HCC). The present study aimed to describe and evaluate patient survival after LT for HBV‐related disease in France and identify the ...Isaure Bienvenue, Olivier Roux, Audrey Coilly, Armand Abergel, Teresa Antonini, Thierry Artzner, Olivier Boillot, Faiza Chermak, Filomena Conti, Sébastien Dharancy, Christophe Duvoux, Laure Elkrief, Marwin Farrugia, Claire Francoz, Baptiste Giguet, Jean Hardwigsen, Pauline Houssel‐Debry, Marie‐Noëlle Hilleret, Nassim Kamar, Marianne Latournerie, Magdalena Meszaros, Sylvie Radenne, Bruno Roche, Ephrem Salamé, Delphine Verhoeven‐Weil, Didier Samuel, Fabien Zoulim, Jérôme Dumortier, François Villeret +28 morewiley +1 more sourceBulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
, 2022 Background & aims: Bulevirtide (BLV) has recently been conditionally approved for the treatment of chronic hepatitis delta (CHD) in Europe, but its effectiveness and safety in patients with compensated cirrhosis and clinically significant portal ...Scholtes C, Monico S, Costantino A, Degasperi E, Sambarino D, Fraquelli M, Zoulim F, Perbellini R, Facchetti F, Borghi M, Ceriotti F, Lampertico P., Uceda Renteria SC, Loglio A, Anolli MP, Scholtes, Caroline, Uceda Renteria, Sara Colonia, Borghi, Marta, Sambarino, Dana, Degasperi, Elisabetta, Lampertico, Pietro, Fraquelli, Mirella, Ceriotti, Ferruccio, Monico, Sara, Zoulim, Fabien, Anolli, Maria Paola, Perbellini, Riccardo, Facchetti, Floriana, Loglio, Alessandro, Costantino, Andrea +29 morecore +1 more sourceDried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring
Liver International, Volume 46, Issue 7, July 2026.ABSTRACT Background and Aims
Chronic hepatitis D is the most severe form of viral hepatitis. Despite recommendations for systematic screening of HBsAg‐positive individuals, hepatitis D infection remains underdiagnosed. Standard HDV virological markers are classically assessed in serum or plasma specimens obtained through venous whole blood sampling ...Rola Matar, Françoise Roudot‐Thoraval, Valérie Ortonne, Olivia Garrigou, Alexandre Soulier, Pierre Cappy, Daniel Candotti, Patrick Ingiliz, Jean‐Michel Pawlotsky, Vincent Leroy, Stéphane Chevaliez +10 morewiley +1 more sourceModern aspects of anti-viral therapy for hepatitis D
Журнал инфектологииViral hepatitis D (HDV infection) worsens the prognosis of HBV infection course in 80-90% of cases, accelerating fibrosis and leading to liver cirrhosis or hepatocellular carcinoma. Hepatitis D affects at least 125 000 people in Russia, and in the world, A. S. Zheleznova, K. A. Svirin, M. Yu. Kartashov +2 moredoaj +1 more sourceReview article: clinical pharmacology of current and investigational hepatitis B virus therapies
, 2020 Contains fulltext :
218239.pdf (Publisher’s version ) (Closed access)BACKGROUND: Treatment of hepatitis B virus (HBV) infection with current therapy suppresses HBV DNA, but loss of hepatitis B surface antigen (HBsAg; functional cure ...Burger, D.M., Smolders, E.J., Kiser, J.J., Feld, J.J., Elise J. Smolders, Jennifer J. Kiser, David M. Burger, Jordan J. Feld +7 morecore +1 more sourceImproving Virological Monitoring of HDV Infection: A Proof-of-Concept Comparative Study of Bosphore and AltoStar® Assays in Patients Treated with Bulevirtide
BiomedicinesHepatitis delta virus (HDV) infection is associated with severe hepatic complications and rapid progression towards liver cirrhosis and hepatocellular carcinoma. Accurate measurement of HDV RNA is critical for monitoring therapeutic responses, especially Verdiana Zulian, Chiara Taibi, Antonio Coppola, Angela Bibbò, Luigi Federici, Martina De Sanctis, Silvia Pauciullo, Gianpiero D’Offizi, Elisa Biliotti, Fiona McPhee, Anna Rosa Garbuglia +10 moredoaj +1 more sourceNationwide Implementation of Double Reflex Testing for Hepatitis Delta in Spain: Results From the Retrospective Phase of the Spain‐DDR Study
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 10, Page 1390-1397, May 2026.Nationwide implementation of double reflex testing for hepatitis delta in Spain markedly increased anti‐HDV and HDV viral load testing between 2022 and 2024, enabling national seroprevalence estimates. Despite this progress, substantial regional heterogeneity persists, highlighting the need for standardised reflex diagnostic protocols.Ana Alberola, Adolfo de Salazar, Ana Fuentes, Raquel Carracedo, Marta Illescas‐López, María del Carmen Rodríguez Baños, Carolina Freyre, Berta Becerril, Isabel Viciana, Inmaculada López‐Rodríguez, Natalia Montiel, Ana María Domínguez Castaño, María Pilar Luzón‐García, Encarnación Ramírez Arellano, Carmen Liébana‐Martos, Francisco Franco Álvarez de Luna, María del Carmen Lozano, Begoña Palop, Antonio Sampedro, Ana Belén Pérez, Sonia Algarate, Susana Rojo Alba, Pablo Fraile, Dolores Ocete, María Jesús Alcaraz, Juan Carlos Rodríguez, Francisco Javier Hernández‐Felices, Olalla Martínez, Victoria Domínguez, Nieves Orta, Dolores Gómez, Carmen Cortell, Jorge Camacho, Susana Sabater, Luis Ángel Iglesias Sánchez, Yasmina Martín, Aldara Vallejo, Lourdes Molina, María Aroca, Beatriz Castro, Magdalena Lara, María José Pena, Ana Rodríguez‐Fernández, Alejandro González Praetorius, José Joaquín Blas, Alicia Beteta, César Gómez, María José Rodríguez, Soledad Illescas, Melanie Abreu, Julio García Díez, Inocencio Beltrán, Marta Sandoval Torrientes, Ruth Sáez, Teresa Martín, Pilar Tajada Alegre, Belén Lorenzo, María Teresa García Valero, Isabel Jiménez Sansegundo, Susana García‐de Cruz, Sonsoles Garcinuño, Miguel Ángel Sáiz, Santiago Muñoz, Isabel Fernández, Helena Miriam Lorenzo Juanes, María Reyes Vidal‐Acuña, Luz María Moldes, Noelia Calvo, Matilde Trigo, María José Gude, Patricia Ordóñez, Sandra Cortizo, Miriam Blasco, Mayra Sigcha, Iker Falces, Juan Carlos Galán, Ana Arribi, Roberto Alonso, Asunción Iborra, María Jesús del Amor Espín, Eva Cascales, Cayetano Pérez, Pablo Fernández, María Dolores Navarro, María Luz Nuñez, Jorge Galán Ros, Luis Javier Gil‐Gallardo, Ana Miqueleiz, Gabriel Reina, Luis Elorduy, Mikele Macho, Carmen Gómez, Paloma Liendo, Yolanda Salicio, Antonio Aguilera, Federico García +95 morewiley +1 more source